We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.38%
2 Healthcare 7.46%
3 Consumer Discretionary 5.14%
4 Industrials 5.11%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEUR icon
6301
iShares Core MSCI Europe ETF
IEUR
$9.46B
-7,596
Closed -$398K
IEZ icon
6302
iShares US Oil Equipment & Services ETF
IEZ
$376M
-14,781
Closed -$286K
IJS icon
6303
iShares S&P Small-Cap 600 Value ETF
IJS
$8.28B
-13,082
Closed -$1.22M
IMA
6304
ImageneBio Inc
IMA
$63.8M
-9,073
Closed -$376K
ILMN icon
6305
Illumina
ILMN
$33.1B
-27,849
Closed -$5.64M
NBP
6306
NovaBridge Biosciences American Depositary Shares
NBP
$217M
-690,767
Closed -$2.39M
IMCR icon
6307
Immunocore
IMCR
$1.9B
-117,603
Closed -$6.71M
IMTE icon
6308
Integrated Media Technology
IMTE
$1.6M
-4,995
Closed -$23K
IMRX icon
6309
Immuneering
IMRX
$338M
-98,786
Closed -$959K
INFU icon
6310
InfuSystem Holdings
INFU
$240M
-134,123
Closed -$1.04M
INNV icon
6311
InnovAge Holding
INNV
$1.51B
-29,408
Closed -$235K
INTT icon
6312
inTEST
INTT
$145M
-64,232
Closed -$1.33M
INVZ icon
6313
Innoviz Technologies
INVZ
$101M
-212,266
Closed -$743K
IOBT
6314
DELISTED
IO Biotech
IOBT
-19,917
Closed -$37K
IONQ icon
6315
IonQ
IONQ
$16.8B
-17,261
Closed -$106K
IR icon
6316
CALL
Ingersoll Rand
IR
$31B
-18,000
Closed -$1.05M
IRON icon
6317
Disc Medicine
IRON
$3.16B
-22,107
Closed -$468K
ISRLU
6318
DELISTED
Israel Acquisitions Corp Unit
ISRLU
-75,000
Closed -$777K
ISTB icon
6319
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.08B
-8,771
Closed -$414K
ITRG
6320
Integra Resources
ITRG
$572M
-51,159
Closed -$70K
IWD icon
6321
iShares Russell 1000 Value ETF
IWD
$84.1B
-36,723
Closed -$5.59M
IWP icon
6322
iShares Russell Mid-Cap Growth ETF
IWP
$20.3B
-59,473
Closed -$5.42M
IXUS icon
6323
iShares Core MSCI Total International Stock ETF
IXUS
$60.5B
-28,869
Closed -$1.79M
IYG icon
6324
iShares US Financial Services ETF
IYG
$2.22B
-39,747
Closed -$2M
IYR icon
6325
CALL
iShares US Real Estate ETF
IYR
$4.65B
-145,000
Closed -$12.3M

Similar funds

Israel Englander's Q2 2023 Portfolio in Review

As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
  • Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.